These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 22459481)
21. Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation. Zheng Y; Murakami M; Takahashi H; Yamauchi M; Kiba A; Yamaguchi S; Yabana N; Alitalo K; Shibuya M Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2019-26. PubMed ID: 16794222 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy. Wood JM Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930 [TBL] [Abstract][Full Text] [Related]
23. Vascular permeability in cardiovascular disease and cancer. Weis SM Curr Opin Hematol; 2008 May; 15(3):243-9. PubMed ID: 18391792 [TBL] [Abstract][Full Text] [Related]
24. Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment. Cuenod CA; Fournier L; Balvay D; Guinebretière JM Abdom Imaging; 2006; 31(2):188-93. PubMed ID: 16447089 [TBL] [Abstract][Full Text] [Related]
25. [The role of immune system in colon metastasis. Lymphangiogenesis or lymphedema in cancer tissue]. Stańczyk M; Olszewski WL; Gewartowska M; Maruszyński M Pol Merkur Lekarski; 2007 May; 22(131):457-9. PubMed ID: 17679395 [TBL] [Abstract][Full Text] [Related]
27. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562 [TBL] [Abstract][Full Text] [Related]
28. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia? Feng S; Huang Y; Chen Z Med Hypotheses; 2011 May; 76(5):618-21. PubMed ID: 21398042 [TBL] [Abstract][Full Text] [Related]
29. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651 [TBL] [Abstract][Full Text] [Related]
31. Flt-1 signaling in macrophages promotes glioma growth in vivo. Kerber M; Reiss Y; Wickersheim A; Jugold M; Kiessling F; Heil M; Tchaikovski V; Waltenberger J; Shibuya M; Plate KH; Machein MR Cancer Res; 2008 Sep; 68(18):7342-51. PubMed ID: 18794121 [TBL] [Abstract][Full Text] [Related]
32. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies. Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290 [TBL] [Abstract][Full Text] [Related]
33. Pathophysiology of tumor angiogenesis and its relevance in renal cell cancer. Strohmeyer D Anticancer Res; 1999; 19(2C):1557-61. PubMed ID: 10365145 [TBL] [Abstract][Full Text] [Related]
34. The enigmatic role of angiopoietin-1 in tumor angiogenesis. Metheny-Barlow LJ; Li LY Cell Res; 2003 Oct; 13(5):309-17. PubMed ID: 14672554 [TBL] [Abstract][Full Text] [Related]
35. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Claffey KP; Brown LF; del Aguila LF; Tognazzi K; Yeo KT; Manseau EJ; Dvorak HF Cancer Res; 1996 Jan; 56(1):172-81. PubMed ID: 8548760 [TBL] [Abstract][Full Text] [Related]
36. [Vascular endothelial growth factor. From basic research to clinical application]. Smirne C; Camandona M; Rosso E; Bellone G; Emanuelli G Minerva Med; 1999; 90(1-2):15-23. PubMed ID: 10388459 [TBL] [Abstract][Full Text] [Related]
37. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091 [TBL] [Abstract][Full Text] [Related]
38. Molecular control of lymphatic metastasis. Achen MG; Stacker SA Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975 [TBL] [Abstract][Full Text] [Related]
39. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability. Tozer GM; Prise VE; Wilson J; Cemazar M; Shan S; Dewhirst MW; Barber PR; Vojnovic B; Chaplin DJ Cancer Res; 2001 Sep; 61(17):6413-22. PubMed ID: 11522635 [TBL] [Abstract][Full Text] [Related]
40. Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis related to or comparable with mechanisms seen in inflammatory pathways? Part II: angiogenesis- and inflammation-related molecular pathways, tumor-associated macrophages, and possible therapeutic implications: a comprehensive review. Laviv Y; Kasper B; Kasper EM Neurosurg Rev; 2018 Oct; 41(4):931-944. PubMed ID: 28283837 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]